Cart
sales@molnova.com
Murrayone
CAS No. 19668-69-0
Murrayone( —— )
Catalog No. M21796 CAS No. 19668-69-0
Murrayone, a coumarin-containing compound extracted from M. paniculata, is the most bioactive substance in this species and is a cancer metastasis chemopreventive agent based on its unique pharmacological properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 186 | In Stock |
|
| 5MG | 211 | In Stock |
|
| 10MG | 359 | In Stock |
|
| 25MG | 595 | In Stock |
|
| 50MG | 821 | In Stock |
|
| 100MG | 1107 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMurrayone
-
NoteResearch use only, not for human use.
-
Brief DescriptionMurrayone, a coumarin-containing compound extracted from M. paniculata, is the most bioactive substance in this species and is a cancer metastasis chemopreventive agent based on its unique pharmacological properties.
-
DescriptionMurrayone, a coumarin-containing compound extracted from M. paniculata, is the most bioactive substance in this species and is a cancer metastasis chemopreventive agent based on its unique pharmacological properties.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number19668-69-0
-
Formula Weight258.27
-
Molecular FormulaC??H??O?
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (193.60 mM)
-
SMILESO=C1C=CC2=CC=C(OC)C(CC(C(C)=C)=O)=C2O1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhai S, et al. A novel UPLC/MS/MS method for rapid determination of murrayone in rat plasma and its pharmacokinetics. J Pharm Biomed Anal. 2020 Feb 20;180:113046.
molnova catalog
related products
-
(-)-Licarin B
1.(-)-Licarin B has anti-mycobacterial activity.
-
[Pyr1]-Apelin-13
[Pyr1]-Apelin-13 is a potent and selective endogenous Apelin receptor (APJ) agonist.[Pyr1]-apelin-13 encapsulation in lipoPEG particles (lipoPEG-PA13) results in sustained and extended drug release under physiological conditions[1].[Pyr1]-apelin-13 nanocarriers in a mouse model of pressure-overload induced heart failure demonstrate a sustainable long-term effect of [Pyr1]-apelin-13 in preventing cardiac dysfunction.
-
Dextrothyroxine
Dextrothyroxine could lower cholesterol and also increases hepatic lipase which in turn improves utilization of triglycerides, leading to improve apolipoprotein E cholesterol particles.
